Doher Drizzle Pablo was drowning in travel receipts. After her company transferred her to Sweden from the Philippines last year, she’d started visiting clients in at least two countries a month, and ...

Microbot Medical ( (MBOT)) has issued an announcement. On November 5, 2025, Microbot Medical announced the limited commercial availability of its LIBERTY® Endovascular Robotic System in the U.S. This ...

Credit: Image generated by VentureBeat with FLUX-pro-1.1-ultra A quiet revolution is reshaping enterprise data engineering. Python developers are building production data pipelines in minutes using ...

Fintel reports that on October 15, 2025, HC Wainwright & Co. reiterated coverage of Microbot Medical (NasdaqCM:MBOT) with a Buy recommendation. Analyst Price Forecast Suggests 325.00% Upside As of ...

We recently published 10 Stocks Losing Big Amid Market Boom. Microbot Medical Inc. (NASDAQ:MBOT) is one of the worst performers on Thursday. Microbot extended its losing streak to a fourth consecutive ...

Microbot Medical announced that the U.S. FDA has granted 510(k) clearance for its LIBERTY® System, the first FDA-cleared single-use, remotely operated robotic system for peripheral endovascular ...

MBOT’s main value driver is its LIBERTY robot. This is a disposable, portable endovascular robot that has great potential. LIBERTY showed strong ACCESS-PVI data and now awaits FDA 510(k) clearance for ...

TIOBE Programming Index News August 2025: AI Copilots Are Boosting Python’s Popularity Your email has been sent Generative AI can be a self-fulfilling prophecy: Because gen AI scans vast amounts of ...

Microbot Medical Inc. (MBOT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

Stefania Druga is a research scientist at Google DeepMind and creator of AI education platform Cognimates. Early AI literacy helps kids develop healthy relationships with the tech as they learn to "co ...